Literature DB >> 11158113

Circulating nucleic acids of Chlamydia pneumoniae and cytomegalovirus in patients undergoing coronary angiography.

M Smieja1, S Chong, M Natarajan, A Petrich, L Rainen, J B Mahony.   

Abstract

Peripheral blood mononuclear cells from 208 consecutive patients undergoing elective coronary angiography or angioplasty were collected before, immediately after, and 4 h after the procedure. Nucleic acids of Chlamydia pneumoniae and of cytomegalovirus (CMV) were detected by PCR and confirmed by hybridization. Circulating C. pneumoniae DNA was identified in 24 patients (11.5%) and was associated with current smoking (odds ratio [OR] = 4.5, 95% confidence interval [CI] = 1.6 to 12.2, P = 0.004) but not with arterial narrowing on coronary angiogram or with serological results positive for C. pneumoniae. Circulating CMV DNA was identified in 36 patients (17.3%) and was associated with anti-CMV immunoglobulin G (OR = 2.7, 95% CI = 1.2 to 6.3, P = 0.02) but not with angiographic arterial narrowing or with the need for revascularization. Neither C. pneumoniae nor CMV DNA detection increased after angioplasty, a procedure in which endothelium is disrupted. Larger prospective studies are needed to determine the prognostic significance of DNA detection.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11158113      PMCID: PMC87782          DOI: 10.1128/JCM.39.2.596-600.2001

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  23 in total

1.  Analytical sensitivity, reproducibility of results, and clinical performance of five PCR assays for detecting Chlamydia pneumoniae DNA in peripheral blood mononuclear cells.

Authors:  J B Mahony; S Chong; B K Coombes; M Smieja; A Petrich
Journal:  J Clin Microbiol       Date:  2000-07       Impact factor: 5.948

2.  Isolation of Chlamydia pneumoniae from a carotid endarterectomy specimen.

Authors:  L A Jackson; L A Campbell; C C Kuo; D I Rodriguez; A Lee; J T Grayston
Journal:  J Infect Dis       Date:  1997-07       Impact factor: 5.226

3.  Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis. The Chlamydia pneumoniae/Atherosclerosis Study Group.

Authors:  J A Ramirez
Journal:  Ann Intern Med       Date:  1996-12-15       Impact factor: 25.391

4.  Detection of Chlamydia pneumoniae and Chlamydia psittaci in sputum samples by PCR.

Authors:  C Y Tong; M Sillis
Journal:  J Clin Pathol       Date:  1993-04       Impact factor: 3.411

5.  Smoking is a potential confounder of the Chlamydia pneumoniae-coronary artery disease association.

Authors:  D L Hahn; R Golubjatnikov
Journal:  Arterioscler Thromb       Date:  1992-08

6.  Polymerase chain reaction assay for detection of human cytomegalovirus.

Authors:  D M Olive; M Simsek; S Al-Mufti
Journal:  J Clin Microbiol       Date:  1989-06       Impact factor: 5.948

7.  Active cytomegalovirus infection of arterial smooth muscle cells in immunocompromised rats. A clue to herpesvirus-associated atherogenesis?

Authors:  M C Persoons; M J Daemen; J H Bruning; C A Bruggeman
Journal:  Circ Res       Date:  1994-08       Impact factor: 17.367

8.  Chlamydia pneumoniae-specific circulating immune complexes in patients with chronic coronary heart disease.

Authors:  E Linnanmäki; M Leinonen; K Mattila; M S Nieminen; V Valtonen; P Saikku
Journal:  Circulation       Date:  1993-04       Impact factor: 29.690

9.  Detection of Chlamydia pneumoniae by polymerase chain reaction.

Authors:  L A Campbell; M Perez Melgosa; D J Hamilton; C C Kuo; J T Grayston
Journal:  J Clin Microbiol       Date:  1992-02       Impact factor: 5.948

10.  Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues.

Authors:  L A Campbell; E R O'Brien; A L Cappuccio; C C Kuo; S P Wang; D Stewart; D L Patton; P K Cummings; J T Grayston
Journal:  J Infect Dis       Date:  1995-08       Impact factor: 5.226

View more
  6 in total

1.  Replicate PCR testing and probit analysis for detection and quantitation of Chlamydia pneumoniae in clinical specimens.

Authors:  M Smieja; J B Mahony; C H Goldsmith; S Chong; A Petrich; M Chernesky
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

2.  Comparison of an industry-derived LCx Chlamydia pneumoniae PCR research kit to in-house assays performed in five laboratories.

Authors:  Max Chernesky; Marek Smieja; Julius Schachter; James Summersgill; Laura Schindler; Natalie Solomon; Karen Campbell; LeeAnn Campbell; Alison Cappuccio; Charlotte Gaydos; Sylvia Chong; Jeanne Moncada; Jack Phillips; Dan Jang; Billie Jo Wood; Astrid Petrich; Margaret Hammerschlag; Mike Cerney; James Mahony
Journal:  J Clin Microbiol       Date:  2002-07       Impact factor: 5.948

3.  Depletion of resident Chlamydia pneumoniae through leukoreduction by filtration of blood for transfusion.

Authors:  Hideaki Ikejima; Herman Friedman; German F Leparc; Yoshimasa Yamamoto
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

4.  Cytomegalovirus in Plasma of Acute Coronary Syndrome Patients.

Authors:  E A Nikitskaya; J C Grivel; E V Maryukhnich; A M Lebedeva; O I Ivanova; P P Savvinova; A V Shpektor; L B Margolis; E Yu Vasilieva
Journal:  Acta Naturae       Date:  2016 Apr-Jun       Impact factor: 1.845

5.  Association of circulating Chlamydia pneumoniae DNA with cardiovascular disease: a systematic review.

Authors:  Marek Smieja; James Mahony; Astrid Petrich; Jens Boman; Max Chernesky
Journal:  BMC Infect Dis       Date:  2002-10-01       Impact factor: 3.090

6.  Smoking, season, and detection of Chlamydia pneumoniae DNA in clinically stable COPD patients.

Authors:  Marek Smieja; Richard Leigh; Astrid Petrich; Sylvia Chong; Dennis Kamada; Frederick E Hargreave; Charles H Goldsmith; Max Chernesky; James B Mahony
Journal:  BMC Infect Dis       Date:  2002-07-05       Impact factor: 3.090

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.